LMP-1 IMMUNOHISTOCHEMICAL DETECTION OF EPSTEIN - BARR VIRUS IN LYMPHOMA AMONG SUDANESE PATIENTS
DOI:
https://doi.org/10.29121/granthaalayah.v3.i9.2015.2946Keywords:
Epstein-Barr Virus, Malignant Lymphomas, Lymph Node Hyperplasia, Lymph Node HyperplasiaImmunohistochemistry, SudanAbstract [English]
Several studies have suggested a probable etiologic association between Epstein-Barr virus (EBV) and lymphoma; multiple EBV proteins can be expressed in infected lymphocytes, among which Latent membrane protein-1(LMP-1) is thought to be most important for malignant transformation, the aim of this study was to investigate the association of LMP-1 EBV in this tumors.
This study was carried at the Radio Isotope Center Khartoum (RICK)- Khartoum state –Sudan from January 2015 to July 2015, it was retrospective and prospective, the study include ninety (90) Formalin –fixed paraffin embedded biopsies from which seventy (70) of malignant lymphoma (study group) and twenty (20) lymph node hyperplasia (control group ).
EBV was detected in (32%) (23/70), and (10%) (2/20) respectively, the (P.value =0.04), this result showed a significant difference between case and control groups, the, there is no statistically significant difference between the two lymphoma subtypes Hodgkin's and Non-Hodgkin`s the (P.value= 0.333).
There is sufficient evidence for the carcinogenicity of EBV in the causation of lymphoma in Sudan. This requires further evaluation to find out whether this positivity is due to co-infection or has a role in pathogenesis.
Downloads
References
Ambinder RF (2007). Epstein-barr virus and Hodgkin lymphoma. Hematology Am SocHematolEduc Program. 2007:204–209. 2007.
Amir Aledavood,1 Mohammad Reza Ghavam Nasiri,1 Bahram Memar,2 Soodabeh Shahidsales,1 Hamid Reza Raziee,1 Kamran Ghafarzadegan,2 and Samira Mohtashami.(2012). Primary gastrointestinal lymphoma .J Res Med Sci; 17(5): 487–490
Chandima P Karunanayake, Helen H McDuffie, James A Dosman John J Spinelli and PunamPahwa, (2008). Occupational exposures and non-Hodgkin's lymphoma: Canadian case-control study. Environmental Health 7:44 doi: 10.1186/1476-069X-7-4
Chandima P Karunanayake, Helen H McDuffie, James A Dosman John J Spinelli and PunamPahwa, (2008). Occupational exposures and non-Hodgkin's lymphoma: Canadian case-control study.Environmental Health 7:44 doi: 10.1186/1476-069X-7-4 DOI: https://doi.org/10.1186/1476-069X-7-4
Flavell KJ and Murray PG (2000). Hodgkin’s disease and the Epstein-Barr virus. MolPathol. 53:262–269.
Gerald Niedobitek, Nadine Meru, Henri-Jacques Delecluse. (2001). Epstein-Barr virus infection and human malignancies. Int J ExpPathol.; 82(3): 149–170.
Gerald Niedobitek, Nadine Meru, Henri-Jacques Delecluse. (2001). Epstein-Barr virus infection and human malignancies. Int J ExpPathol.; 82(3): 149–170.
Gulley ML, Glaser SL, Craig FE, et al (2002). Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma. Am J ClinPathol. 117:259–267.
MacMahon B. (1957). Epidemiological evidence of the nature of Hodgkin’s disease. Cancer ; 10: 1045–54.
MacMahon B.(1966). Epidemiology of Hodgkin’s disease. Cancer Res 1966; 26: 1189–201.
Mao Y, Lu MP, Lin H, et al (2013). Prognostic Significance of EBV Latent Membrane Protein 1 Expression in Lymphomas: Evidence from 15 Studies. PLoS One, 8, 60313. DOI: https://doi.org/10.1371/journal.pone.0060313
Mueller NE, Grufferman S, Chang ET (2007). The epidemiology of Hodgkin lymphoma. In: HoppeRT, MauchPM, ArmitageJO, DiehlV, WeissLM, eds. Hodgkin Lymphoma. Philadelphia: Wolters Kluwer, ; 7–23.
Mushtaq S, Akhtar N, Jamal S, et al (2008). Malignant Lymphomas in Pakistan According to WHO Classification of Lymphoid Neoplasms. Asian Pac J Cancer Prev, 9, 229-32
Nourse JP, Crooks P, Keane C, et al (2012). Expression profiling of Epstein-Barr virus-encoded microRNAs from paraffin-embedded formalin-fixed primary Epstein-Barr virus-positive B-cell lymphoma samples. J Virol Methods, 184, 46-54 DOI: https://doi.org/10.1016/j.jviromet.2012.05.005
Orem J, Mbidde EK, Lambert B, de Sanjose S, Weiderpass E. (2007). Burkitt’s lymphoma in Africa, a review of the epidemiology and etiology. Afr Health Sci.; 7(3): 166-75.
Stein H, Delsol G, Pileri S et al. (2001). Hodgkin lymphoma. In: JaffeE, HarrisNL, SteinH, VardimanJW, eds. Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 237–53.
Stewart BW, Kleihues P, eds., (2003). World Cancer Report. Lyon: IARC Press ,1–342.
Wang JK, Wang YZ, Chen ZW, Taylor RC. (2006). Prevalence of lymphoma subtypes in Shanxi according to WHO classification. Chinese J pathol.; 35(4):218-23.
Wang JK, Wang YZ, Chen ZW, Taylor RC. (2006). Prevalence of lymphoma subtypes in Shanxi according to WHO classification. Chinese J pathol.; 35(4):218-23.
Williams H, Crawford DH (2006). Epstein-Barr virus: the impact of scientific advances on clinical practice. Blood, 107, 862-69.0 DOI: https://doi.org/10.1182/blood-2005-07-2702
Downloads
Published
How to Cite
Issue
Section
License
With the licence CC-BY, authors retain the copyright, allowing anyone to download, reuse, re-print, modify, distribute, and/or copy their contribution. The work must be properly attributed to its author.
It is not necessary to ask for further permission from the author or journal board.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
